Archive

Pierluigi Paracchi is Co-Founder and Venture Consultant of AurorA-TT, a Technology Transfer initiative fully focused in the biotech sector, and Co-Founder, Board Member of Altheia Science. He has more than 15 years of experience as Venture Capitalist and Biotech Entrepreneur. He was Founder & CEO of...

– 35 years at global top positions in big pharmaceuticals at all levels. Managed staff over 7,000 employees with turnover over 7b€ – Head Pharma Region Europe Novartis – Head Oncology Europe Novartis – Brought various drugs from clinical development to market in oncology and general medicine among them Cosentyx, Entresto, Lucentis, Gilenya, Xolair, Ultibro, Seebri, Galvus,...

Gabriele Campi, PhD is an immunologist with an integrate background sharing 10+ years of academic research between San Raffaele Hospital, Milan and New York University, New York City and 6+ years in Venture Capital and Technology Transfer with different positions in VC funds in Italy,...

– 20 years in BioPharma, Medical Devices and Consulting with different management roles in various European countries. Managed staff over 100 employees with turnover over 30M€ – CEO Inorgen (Drug Discovery Engine), UK and Italy – Deployment of the business model, marketing with pharma companies, VCs and relevant stakeholders for partnering activities – Agreement with...

Paolo Rizzardi, MD, internist, is Co-Founder and Managing Partner of AurorA-TT, a Technology Transfer initiative fully focused in the biotech sector, and Co-Founder, Chairman&CEO of Altheia Science. He combines a strong scientific background with managerial skills gained in substantially contributing to successfully develop biotechnology companies...